uric acid has been researched along with Nephrosis in 11 studies
Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.
Nephrosis: Pathological processes of the KIDNEY without inflammatory or neoplastic components. Nephrosis may be a primary disorder or secondary complication of other diseases. It is characterized by the NEPHROTIC SYNDROME indicating the presence of PROTEINURIA and HYPOALBUMINEMIA with accompanying EDEMA.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Puromycin aminonucleoside nephrosis (PAN) is a rat model of minimal change nephrotic syndrome." | 7.85 | Renoprotective effect of topiroxostat via antioxidant activity in puromycin aminonucleoside nephrosis rats. ( Fujigaki, Y; Hosoyamada, M; Kawamorita, Y; Kumagai, T; Nakagawa, T; Shibata, S; Shiraishi, T; Tamura, Y; Uchida, S, 2017) |
| "To observe the ameliorative effect of Zishen Decoction (ZSD) on chronic uric acid nephrosis (CUAN)." | 7.70 | [Clinical study on Zishen Decoction in chronic uric acid nephrosis]. ( Ni, Q; Shi, Z; Zheng, Q, 1998) |
| " The hypothesis was tested that the renal xanthine oxidase system provides a source of oxygen free radicals in puromycin aminonucleoside and adriamycin experimental nephrosis by generating uric acid from hypoxanthine and xanthine." | 7.68 | Renal purine efflux and xanthine oxidase activity during experimental nephrosis in rats: difference between puromycin aminonucleoside and adriamycin nephrosis. ( Acerbo, S; Allegrini, S; Bertelli, R; Cercignani, G; D'Allegri, F; Ghiggeri, G; Ginevri, F; Gusmano, R; Oleggini, R; Perfumo, F, 1990) |
| " Puromycin aminonucleoside nephrosis (PAN) is a rat model of minimal change nephrotic syndrome." | 3.85 | Renoprotective effect of topiroxostat via antioxidant activity in puromycin aminonucleoside nephrosis rats. ( Fujigaki, Y; Hosoyamada, M; Kawamorita, Y; Kumagai, T; Nakagawa, T; Shibata, S; Shiraishi, T; Tamura, Y; Uchida, S, 2017) |
| "To observe the ameliorative effect of Zishen Decoction (ZSD) on chronic uric acid nephrosis (CUAN)." | 3.70 | [Clinical study on Zishen Decoction in chronic uric acid nephrosis]. ( Ni, Q; Shi, Z; Zheng, Q, 1998) |
| " The hypothesis was tested that the renal xanthine oxidase system provides a source of oxygen free radicals in puromycin aminonucleoside and adriamycin experimental nephrosis by generating uric acid from hypoxanthine and xanthine." | 3.68 | Renal purine efflux and xanthine oxidase activity during experimental nephrosis in rats: difference between puromycin aminonucleoside and adriamycin nephrosis. ( Acerbo, S; Allegrini, S; Bertelli, R; Cercignani, G; D'Allegri, F; Ghiggeri, G; Ginevri, F; Gusmano, R; Oleggini, R; Perfumo, F, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (54.55) | 18.7374 |
| 1990's | 3 (27.27) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kawamorita, Y | 1 |
| Shiraishi, T | 1 |
| Tamura, Y | 1 |
| Kumagai, T | 1 |
| Shibata, S | 1 |
| Fujigaki, Y | 1 |
| Hosoyamada, M | 1 |
| Nakagawa, T | 1 |
| Uchida, S | 1 |
| Jin, X | 1 |
| Lok, E | 1 |
| Caldwell, D | 1 |
| Mueller, R | 1 |
| Kapal, K | 1 |
| Liston, V | 1 |
| Kubow, S | 1 |
| Chan, HM | 1 |
| Mehta, R | 1 |
| BROPHY, EM | 1 |
| ASHWORTH, CT | 1 |
| ARIAS, M | 1 |
| REYNOLDS, J | 1 |
| RIESELBACH, RE | 1 |
| BENTZEL, CJ | 1 |
| COTLOVE, E | 1 |
| FREI, E | 1 |
| FREIREICH, EJ | 1 |
| Futrakul, P | 1 |
| Yenrudi, S | 1 |
| Futrakul, N | 1 |
| Sensirivatana, R | 1 |
| Kingwatanakul, P | 1 |
| Jungthirapanich, J | 1 |
| Cherdkiadtikul, T | 1 |
| Laohapaibul, A | 1 |
| Watana, D | 1 |
| Singkhwa, V | 1 |
| Futrakul, S | 1 |
| Pongsin, P | 1 |
| Ni, Q | 1 |
| Shi, Z | 1 |
| Zheng, Q | 1 |
| Ginevri, F | 1 |
| Gusmano, R | 1 |
| Oleggini, R | 1 |
| Acerbo, S | 1 |
| Bertelli, R | 1 |
| Perfumo, F | 1 |
| Cercignani, G | 1 |
| Allegrini, S | 1 |
| D'Allegri, F | 1 |
| Ghiggeri, G | 1 |
| Bhambal, SA | 1 |
| Sharma, KS | 1 |
| Bhambal, S | 1 |
| Richter, R | 1 |
| Hermanny, G | 1 |
| Hofer, E | 1 |
| Stobbe, H | 1 |
| Doliopoulos, T | 1 |
| Liaskou, F | 1 |
| Marousis, S | 1 |
| Heath, BC | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Use of IL-2 for Pediatric, Multi Drug Resistant, Idiopathic Nephrotic Syndrome[NCT02455908] | Phase 1/Phase 2 | 5 participants (Actual) | Interventional | 2012-02-29 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
11 other studies available for uric acid and Nephrosis
| Article | Year |
|---|---|
Renoprotective effect of topiroxostat via antioxidant activity in puromycin aminonucleoside nephrosis rats.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Antioxidants; Cell Line; Deoxyguanosine; Enzyme Inhibitors; Ki | 2017 |
Dietary fats altered nephrotoxicity profile of methylmercury in rats.
Topics: Animals; Blood Urea Nitrogen; Body Weight; Calcium; Cholesterol; Creatinine; Diet; Dietary Fats; Doc | 2009 |
ACUTE SYPHILITIC NEPHROSIS IN PREGNANCY.
Topics: Blood Protein Electrophoresis; Bone Diseases; Communicable Diseases; Electrons; Female; Fluorescent | 1964 |
URIC ACID EXCRETION AND RENAL FUNCTION IN THE ACUTE HYPERURICEMIA OF LEUKEMIA. PATHOGENESIS AND THERAPY OF URIC ACID NEPHROPATHY.
Topics: Acetazolamide; Bicarbonates; Blood; Carbon Isotopes; Drug Therapy; Fluids and Secretions; Hippurates | 1964 |
Tubular function and tubulointerstitial disease.
Topics: Adolescent; Biological Transport; Calcium; Child; Female; Glomerular Mesangium; Glomerulonephritis; | 1999 |
[Clinical study on Zishen Decoction in chronic uric acid nephrosis].
Topics: Adult; Aged; Chronic Disease; Drugs, Chinese Herbal; Female; Humans; Male; Middle Aged; Nephrosis; Q | 1998 |
Renal purine efflux and xanthine oxidase activity during experimental nephrosis in rats: difference between puromycin aminonucleoside and adriamycin nephrosis.
Topics: Allantoin; Animals; Doxorubicin; Hypoxanthines; Kidney; Male; Nephrosis; Proteinuria; Purines; Purom | 1990 |
Relationship between short duration and 24-hour urinary excretion pattern of some nitrogenous compounds.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Creatine; Creatinine; Hepatitis A; Humans; Liver C | 1972 |
[Secondary hyperuricemia in hemoblastosis].
Topics: Blood Cell Count; Humans; Leukemia; Myeloproliferative Disorders; Nephrosis; Polycythemia Vera; Prim | 1971 |
Comparison of the action of two new oral diuretics, the 4-chloro-N-methyl-3-(methylsulfamoly) benzamide and 4-chloro-3-sulfamylbenzoic acid 2,2-dimethylhydrazide (a study on 102 patients).
Topics: Adult; Aged; Arteries; Blood Glucose; Blood Pressure; Body Weight; Diuretics; Edema; Heart Failure; | 1968 |
Chemical pathology of nephrosis induced by an infectious bronchitis virus.
Topics: Animals; Blood Glucose; Calcium; Chickens; Food; Hematocrit; Hydrogen-Ion Concentration; Muscles; Ne | 1970 |